Cwm LLC Sells 993 Shares of Avantor, Inc. (NYSE:AVTR)

Cwm LLC trimmed its position in shares of Avantor, Inc. (NYSE:AVTR) by 21.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,643 shares of the company’s stock after selling 993 shares during the quarter. Cwm LLC’s holdings in Avantor were worth $94,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Versant Capital Management Inc boosted its position in shares of Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the period. GAMMA Investing LLC raised its holdings in shares of Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after acquiring an additional 1,285 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in shares of Avantor during the first quarter worth $93,000. Finally, ORG Partners LLC raised its holdings in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after acquiring an additional 5,773 shares during the period. 95.08% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

Avantor Stock Performance

AVTR opened at $22.43 on Friday. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $28.00. The stock has a market cap of $15.24 billion, a price-to-earnings ratio of 57.51, a PEG ratio of 2.93 and a beta of 1.33. The business has a 50 day moving average of $25.49 and a 200-day moving average of $24.26. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Friday, October 25th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.01. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.72 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, equities research analysts expect that Avantor, Inc. will post 1.01 earnings per share for the current year.

Analyst Ratings Changes

AVTR has been the topic of a number of research analyst reports. Citigroup lowered shares of Avantor from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $30.00 to $23.00 in a report on Wednesday, July 10th. Stifel Nicolaus raised their price objective on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Robert W. Baird raised their price objective on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Evercore ISI lowered their price target on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Finally, TD Cowen lifted their price target on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.79.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.